Literature DB >> 7719419

Steatorrhea in Japanese patients with chronic pancreatitis.

T Nakamura1, K Takebe, K Kudoh, M Ishii, K Iamura, H Kikuchi, F Kasai, Y Tandoh, N Yamada, Y Arai.   

Abstract

Fecal fat excretion, fecal mass, fecal fat concentration, and the coefficient of fat absorption were evaluated in 31 normal Japanese subjects with a mean fat consumption of 61.8 g and compared with the values in 43 Japanese patients with chronic pancreatitis (CP) with a fat consumption of 40.2 g. Fecal fatty acids were analyzed by the gas chromatographic method. Fecal fat excretion by normal individuals was 1.7 +/- 1.0 (Mean +/- SD) g/day (range, 0.4-4.9 g/day). Steatorrhea was therefore defined as fecal fat excretion that exceeded 5.0 g/day. The patients with CP were divided into three groups: non-steatorrhea (fecal fat < 5.0 g/day), chemical steatorrhea (fecal fat > or = 5 g/day and no appearance of fatty stool), and manifest steatorrhea (evaluated from the appearance of fatty stool). In addition, we investigated the correlation between fecal fat excretion and pancreatic exocrine function, obtained by the pancreozymin-secretin (or secretin) test in 24 controls and 30 CP patients. Fecal fat excretion by CP patients was 9.1 +/- 8.8 g/day, which was significantly higher (P < 0.01) than that of controls. There were 28 (65%) CP patients with steatorrhea. Of these, 15 (35%) showed chemical steatorrhea and 13 (30%) manifest steatorrhea. In CP patients, the fecal mass (250.5 +/- 133.6 g vs control, 125.6 +/- 52.5 g), fecal fat concentration (3.40 +/- 2.16 g% vs control, 1.48 +/- 0.89 g%), and coefficient of fat absorption (77.3 +/- 20.2% vs control, 97.2 +/- 1.7%) all showed significant differences from the controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719419     DOI: 10.1007/bf01211379

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  11 in total

1.  Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.

Authors:  D Y Graham
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

2.  Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.

Authors:  E P DiMagno; J R Malagelada; V L Go; C G Moertel
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

3.  Correlation of radioactive and chemical fecal fat determinations in various malabsorption syndromes.

Authors:  B D PIMPARKAR; E G TULSKY; W H KALSER; H L BOCKUS
Journal:  Am J Med       Date:  1961-06       Impact factor: 4.965

4.  Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency.

Authors:  E P DiMagno; V L Go; W H Summerskill
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

5.  Correlation between bile acid malabsorption and pancreatic exocrine dysfunction in patients with chronic pancreatitis.

Authors:  T Nakamura; H Kikuchi; K Takebe; M Ishii; K Imamura; N Yamada; K Kudoh; A Terada
Journal:  Pancreas       Date:  1994-09       Impact factor: 3.327

6.  Faecal lipid excretion levels in normal Japanese females on an unrestricted diet and a fat-restricted diet measured by simultaneous analysis of faecal lipids.

Authors:  T Nakamura; H Kikuchi; K Takebe; K Kudoh; A Terada; Y Tan-Doh; N Yamada
Journal:  J Int Med Res       Date:  1992-11       Impact factor: 1.671

7.  The interrelationships of pancreatic enzymes in human duodenal aspirate.

Authors:  D M Goldberg; K G Wormsley
Journal:  Gut       Date:  1970-10       Impact factor: 23.059

8.  Separation and quantitation of fatty acids, sterols and bile acids in feces by gas chromatography as the butyl ester-acetate derivatives.

Authors:  P Child; M Aloe; D Mee
Journal:  J Chromatogr       Date:  1987-03-20

9.  Utility of fecal fat concentrations as screening test in pancreatic insufficiency.

Authors:  I M Roberts; C Poturich; A Wald
Journal:  Dig Dis Sci       Date:  1986-10       Impact factor: 3.199

10.  Raised fecal fat concentration is not a valid indicator of pancreatic steatorrhea.

Authors:  B Lembcke; K Grimm; P G Lankisch
Journal:  Am J Gastroenterol       Date:  1987-06       Impact factor: 10.864

View more
  5 in total

1.  Near-infrared spectrometry analysis of fat, neutral sterols, bile acids, and short-chain fatty acids in the feces of patients with pancreatic maldigestion and malabsorption.

Authors:  T Nakamura; T Takeuchi; A Terada; Y Tando; T Suda
Journal:  Int J Pancreatol       Date:  1998-04

2.  Can pancreatic steatorrhea be diagnosed without chemical analysis?

Authors:  T Nakamura; Y Tando; A Terada; T Watanabe; A Kaji; N Yamada; T Suda
Journal:  Int J Pancreatol       Date:  1997-10

3.  Effects of high-lipase pancreatin on fecal fat, neutral sterol, bile acid, and short-chain fatty acid excretion in patients with pancreatic insufficiency resulting from chronic pancreatitis.

Authors:  T Nakamura; Y Tandoh; A Terada; N Yamada; T Watanabe; A Kaji; K Imamura; H Kikuchi; T Suda
Journal:  Int J Pancreatol       Date:  1998-02

4.  High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study.

Authors:  Philip D Hardt; Annette Hauenschild; Clemens Jaeger; Joachim Teichmann; Reinhard G Bretzel; Hans U Kloer
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

5.  Effect of pancrelipase in preventing pancreatic dysfunction after pancreaticoduodenectomy.

Authors:  Yukio Asano; Akihiko Horiguchi; Masahiro Ito; Satoshi Arakawa; Shinpei Furuta; Masahiro Shimura; Chihiro Hayashi; Kenshiro Kamio; Toki Kawai; Hironobu Yasuoka; Takahiko Higashiguchi
Journal:  Fujita Med J       Date:  2019-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.